COVID-19 in Africa: Here's what's at stake 

A volunteer receives an injection from a medical worker during the country's first human clinical trial for a potential vaccine against the novel coronavirus, at the Baragwanath hospital in Soweto, South Africa, June 24, 2020. REUTERS/Siphiwe Sibeko - RC2PFH9P3529

Each year, 2.6 million people in Africa develop TB. Image: REUTERS/Siphiwe Sibeko - RC2PFH9P3529

Winnie Byanyima
Undersecretary-General of the United Nations; Executive Director, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Lucica Ditiu
Executive Director, Stop TB Partnership
Abdourahmane Diallo
CEO, RBM Partnership to End Malaria
Share:
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Have you read?
Coronavirus Covid-19 virus infection China Hubei Wuhan contagion spread economics dow jones S&P 500 stock market crash 1929 depression great recession
Africa accounted for 380,000 malaria deaths IN 2018. Image: WHO
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

About Us

Events

Media

More from the Forum

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum